Jinrui Foundation Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

Jinrui Foundation General Information

Description

Developer of innovative medicines designed to cure malignant tumors and other diseases. The company's focuses on the research and development of Tumor Detection Kit, Anticancer Drugs, Tumor Vaccine and Inflammatory Drugs, providing patients with advanced treatment on severe diseases.

Contact Information

Website
www.jrfbio.com
Formerly Known As
Chengdu Jinrui Investment Development Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 2004, Building 1, No. 333, North Section of Yizhou Avenue
  • High-tech Zone
  • Chengdu, Sichuan 610000
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • Room 2004, Building 1, No. 333, North Section of Yizhou Avenue
  • High-tech Zone
  • Chengdu, Sichuan 610000
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jinrui Foundation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 28-Jul-2023 Completed Clinical Trials - General
2. Later Stage VC 13-Dec-2022 Completed Clinical Trials - General
1. Later Stage VC 22-Nov-2021 Completed Clinical Trials - General
To view Jinrui Foundation’s complete valuation and funding history, request access »

Jinrui Foundation Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

Jinrui Foundation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025223276-A1 Honokiol liposome lyophilized agent and preparation method therefor Pending 24-Apr-2024
US-20240366527-A1 Honokiol liposome transdermal gel, preparation method and use thereof Pending 19-Jul-2023
WO-2025002355-A1 Crystal form of jak2 inhibitor and preparation method Inactive 29-Jun-2023
WO-2025002355-A9 Crystal form of jak2 inhibitor and preparation method Inactive 29-Jun-2023
WO-2024193393-A1 Crystal form of heteropyridopyrimidinone derivative and preparation method therefor Inactive 17-Mar-2023 C07D498/04
To view Jinrui Foundation’s complete patent history, request access »

Jinrui Foundation Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Joincare Pharmaceutical Group Industry Company Corporation Minority
To view Jinrui Foundation’s complete investors history, request access »

Ready to get started?

Request a free trial

Jinrui Foundation FAQs

  • When was Jinrui Foundation founded?

    Jinrui Foundation was founded in 2009.

  • Where is Jinrui Foundation headquartered?

    Jinrui Foundation is headquartered in Chengdu, China.

  • What industry is Jinrui Foundation in?

    Jinrui Foundation’s primary industry is Drug Discovery.

  • Is Jinrui Foundation a private or public company?

    Jinrui Foundation is a Private company.

  • What is Jinrui Foundation’s current revenue?

    The current revenue for Jinrui Foundation is .

  • Who are Jinrui Foundation’s investors?

    Joincare Pharmaceutical Group Industry Company has invested in Jinrui Foundation.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process